Selecta Biosciences Inc.

2.57-0.0400-1.53%Vol 443.53K1Y Perf 50.88%
Aug 14th, 2020 16:00 DELAYED
BID2.57 ASK2.58
Open2.62 Previous Close2.61
Pre-Market2.62 After-Market2.59
 0.01 0.38%  0.02 0.78%
Target Price
7.75 
Analyst Rating
Strong Buy 1.33
Potential %
201.56 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-100/-33/-20 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-100/-44/-27 
Growth Ranking
★+     43.28
Insiders Shares Cnt. % 3/6/12 mo.
-100/-14/-16 
Income Ranking
 —    -
Market Cap275.36M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
36.34 
Earnings Date
6th Aug 2020

Today's Price Range

2.552.63

52W Range

1.284.83

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-3.02%
1 Month
1.58%
3 Months
-20.68%
6 Months
-38.22%
1 Year
50.88%
3 Years
-83.64%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
SELB2.57-0.0400-1.53
AAPL459.63-0.4100-0.09
GOOG1 507.73-10.7200-0.71
MSFT208.900.20000.10
XOM43.200.19000.44
WFC25.300.28001.12
JNJ148.240.24000.16
FB261.24-0.0600-0.02
GE6.660.06000.91
JPM102.410.04000.04
Financial StrengthValueIndustryS&P 500US Markets
2.40
2.50
-
2.30
-44.10
Leverage Ratio -364.00
ProfitabilityValueIndustryS&P 500US Markets
-
-922.50
-891.30
-8 097.40
-
RevenueValueIndustryS&P 500US Markets
6.65M
0.06
60.77
-2.56
Earnings HistoryEstimateReportedSurprise %
Q02 20200.32-0.17-153.12
Q01 2020-0.27-0.2122.22
Q04 2019-0.19-0.28-47.37
Q03 2019-0.28-0.267.14
Q02 2019-0.34-0.37-8.82
Q01 2019-0.37-0.3116.22
Q04 2018-0.76-0.6514.47
Q03 2018-0.79-0.7110.13
Earnings Per EndEstimateRevision %Trend
9/2020 QR-0.1236.84Positive
12/2020 QR-0.1242.86Positive
12/2020 FY-0.3062.96Positive
12/2021 FY-0.4247.50Positive
Next Report Date-
Estimated EPS Next Report0.32
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume443.53K
Shares Outstanding107.14M
Trades Count2.85K
Dollar Volume1.17M
Avg. Volume1.42M
Avg. Weekly Volume818.48K
Avg. Monthly Volume1.02M
Avg. Quarterly Volume2.39M

Selecta Biosciences Inc. (NASDAQ: SELB) stock closed at 2.57 per share at the end of the most recent trading day (a -1.53% change compared to the prior day closing price) with a volume of 447.66K shares and market capitalization of 275.36M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 39 people. Selecta Biosciences Inc. CEO is Carsten Brunn.

The one-year performance of Selecta Biosciences Inc. stock is 50.88%, while year-to-date (YTD) performance is 7.98%. SELB stock has a five-year performance of %. Its 52-week range is between 1.28 and 4.83, which gives SELB stock a 52-week price range ratio of 36.34%

Selecta Biosciences Inc. currently has a PE ratio of -, a price-to-book (PB) ratio of 28.13, a price-to-sale (PS) ratio of 43.64, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -83.79%, a ROC of -182.90% and a ROE of -2 175.61%. The company’s profit margin is -%, its EBITDA margin is -891.30%, and its revenue ttm is $6.65 Million , which makes it $0.06 revenue per share.

Of the last four earnings reports from Selecta Biosciences Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.32 for the next earnings report. Selecta Biosciences Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Selecta Biosciences Inc. is Strong Buy (1.33), with a target price of $7.75, which is +201.56% compared to the current price. The earnings rating for Selecta Biosciences Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Selecta Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Selecta Biosciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.79, ATR14 : 0.19, CCI20 : -18.70, Chaikin Money Flow : 0.11, MACD : -0.04, Money Flow Index : 55.27, ROC : 0.78, RSI : 45.71, STOCH (14,3) : 49.02, STOCH RSI : 0.28, UO : 46.66, Williams %R : -50.98), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Selecta Biosciences Inc. in the last 12-months were: Carsten Brunn (Option Excercise at a value of $0), Carsten Brunn (Sold 20 899 shares of value $47 377 ), Lloyd Johnston (Option Excercise at a value of $2 410), Timothy C. Barabe (Buy at a value of $10 000), Timothy C. Barabe (Sold 0 shares of value $-43 841 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (83.33 %)
6 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (16.67 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.33
Strong Buy
1.00
Strong Buy
1.00

Selecta Biosciences Inc.

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company is engaged in using synthetic vaccine particle or SVP technology to discover and develop targeted therapies to modulate the immune system effectively and safely treat rare and serious diseases. It provides SVP for immune tolerance and stimulation. The company products in Phase 1 and Phase 2 include SEL-403 for Pancreatic Cancer and Mesothelioma, SEL-212 for Chronic Severe Gout, SEL-302 for Methylmalonic Acidemia (MMA) and SEL-313 for Ornithine Transcarbamylase Deficiency (OTC).

CEO: Carsten Brunn

Teplephone: +1 617 923-1400

Address: 480 Arsenal Way, Watertown 02472, MA, USA

Number of employees: 39

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

43%57%

Bearish Bullish

51%49%

News

Stocktwits